Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Parallel, Multicenter Study of Axid (Nizatidine) Oral Solution in the Treatment of Gastroesophageal Reflux Disease (GERD) Symptoms in Infants Age 30 Days-1 Year

NCT00373334 is registered in ClinicalTrials.gov with Braintree Laboratories as lead sponsor.

NCT NCT00373334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00373334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Parallel, Multicenter Study of Axid (Nizatidine) Oral Solution in the Treatment of Gastroesophageal Reflux Disease (GERD) Symptoms in Infants Age 30 Days-1 Year
Lead sponsor
Braintree Laboratories
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
February 29, 2008
Enrollment
138 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease, gerd, heartburn